1)味岡洋一.大腸の生検標本の読み方─炎症性腸疾患.G.I.Res 15:147-153, 2007
2)Matts SG. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 30:393-407, 1961
3)Riley SA, Mani V, Goodman MJ, et al. Microscopic activity in ulcerative colitis:what does it mean? Gut 32:174-178, 1991
4)Geboes K, Riddell R, Ost A, et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 47:404-409, 2000
5)Florén CH, Benoni C, Willén R. Histologic and colonoscopic assessment of disease extention in ulcrative colitis. Scand J Gastroenterol 22:459-462, 1987
6)Sandborn WJ, Tremaine WJ, Schroeder KW, et al. A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis. Gastroenterology 106:1429-1435, 1994
7)Jewell DP. Ulcerative colitis. In Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisenger and Fordran's Gastrointestinal and liver disease:Pathology/diagnosis/management, 6th ed. W.B.Saunders, Pholadelphia, pp 1743-1744, 1998
8)D'Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114:262-267, 1998
9)潰瘍性大腸炎・クローン病診断基準・治療指針.「難治性炎症性腸疾患障害に関する調査研究」(鈴木班),平成28年度分担研究報告書,平成28年度改訂版(平成29年3月31日).厚生労働科学研究費補助金難治性疾患等政策研究事業,2017
10)岩下明德,尾石樹泰,蒲池紫乃,他.潰瘍性大腸炎・Crohn病の鑑別診断における生検の役割─病理の立場から.胃と腸 35:159-166, 2000
11)Mojahed A, Khanna R, Sandborn WJ, et al. Assessment of histologic disease activity in Crohn's disease:A systematic review. Inflamm Bowel Dis 20:2092-2103, 2014
12)岩下明德,山田豊,喜多村邦弘,他.Crohn病─病理診断.胃と腸 32:365-376, 1997
13)Binder V. The content of esoniophil granulocytes in the colonic mucosa inulcerative colitis. Scand J Gastroenterol 5:707-712, 1970
14)Sarin SK, Malhotra V, Sen Gupta S, et al. Significance of eosinophil cell and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sci 32:363-367, 1987
15)江頭由太郎,藤井基嗣,西田司,他.難治性潰瘍性大腸炎の組織学的特徴─初発時の生検組織像による難治化症例の予測.胃と腸 46:1947-1955, 2011